{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20241220",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "80676",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761315s000lbl.pdf",
              "date": "20241220",
              "type": "Label"
            },
            {
              "id": "80745",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761315Orig1s000ltr.pdf",
              "date": "20241227",
              "type": "Letter"
            },
            {
              "id": "80919",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/761315Orig1s000TOC.html",
              "date": "20250205",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20250731",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "83021",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761315Orig1s003ltr.pdf",
              "date": "20250801",
              "type": "Letter"
            },
            {
              "id": "83029",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761315s003lbl.pdf",
              "date": "20250801",
              "type": "Label"
            },
            {
              "id": "83030",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761315s003lbl.pdf#page=12",
              "date": "20250801",
              "type": "Medication Guide"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20250502",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "82261",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761315s001lbl.pdf",
              "date": "20250502",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA761315",
      "sponsor_name": "NOVO NORDISK INC",
      "openfda": {
        "application_number": [
          "BLA761315"
        ],
        "brand_name": [
          "ALHEMO"
        ],
        "generic_name": [
          "CONCIZUMAB"
        ],
        "manufacturer_name": [
          "Novo Nordisk"
        ],
        "product_ndc": [
          "0169-2080",
          "0169-2084",
          "0169-2081"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "CONCIZUMAB"
        ],
        "rxcui": [
          "2708346",
          "2708353",
          "2708356",
          "2708359",
          "2708361",
          "2708362"
        ],
        "spl_id": [
          "ff2589ac-650f-4740-984d-e950f785c1fc"
        ],
        "spl_set_id": [
          "156f6404-1f6f-417f-bcf8-f07a27a82cc1"
        ],
        "package_ndc": [
          "0169-2084-15",
          "0169-2080-15",
          "0169-2081-03"
        ],
        "nui": [
          "N0000194160",
          "N0000194161"
        ],
        "pharm_class_epc": [
          "Tissue Factor Pathway Inhibitor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Tissue Factor Pathway Inhibitor Antagonists [MoA]"
        ],
        "unii": [
          "68603V9EAF"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "ALHEMO",
          "active_ingredients": [
            {
              "name": "CONCIZUMAB-MTCI",
              "strength": "150MG/1.5ML(100MG/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "Injectable",
          "route": "Subcutaneous",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "003",
          "reference_drug": "No",
          "brand_name": "ALHEMO",
          "active_ingredients": [
            {
              "name": "CONCIZUMAB-MTCI",
              "strength": "300MG/3ML(100MG/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "Injectable",
          "route": "Subcutaneous",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "ALHEMO",
          "active_ingredients": [
            {
              "name": "CONCIZUMAB-MTCI",
              "strength": "60MG/1.5ML(40MG/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "Injectable",
          "route": "Subcutaneous",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}